Premium
Enolase‐phosphatase 1 acts as an oncogenic driver in glioma
Author(s) -
Wang Bo,
Xu Xin,
Liu Xi,
Wang Dong,
Zhuang Hao,
He Xin,
Han Tong,
Hong Jian
Publication year - 2021
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.29926
Subject(s) - gene knockdown , glioma , pi3k/akt/mtor pathway , cancer research , enolase , cell growth , protein kinase b , phosphatase , biology , signal transduction , microbiology and biotechnology , chemistry , phosphorylation , immunohistochemistry , apoptosis , immunology , biochemistry
Enolase‐phosphatase 1 (ENOPH1), a newly identified enzyme involved in l ‐methionine biosynthesis, is associated with anxiety and depression. In this study, ENOPH1 was found to play a crucial role in promoting the proliferation and migration of glioma cells. Among high‐grade glioma patients, the overall survival of the group showing high ENOPH1 expression was shorter than that of the group showing low ENOPH1 expression. ENOPH1 knockdown inhibited glioma cell proliferation and migration. In parallel, ENOPH1 knockdown suppressed tumor growth capacity and prolonged survival in an orthotopic glioma model. Mechanistically, we found that ENOPH1 activates the PI3K/AKT/mTOR signaling pathway by regulating THEM4. In conclusion, ENOPH1 is an important mediator that promotes glioma cell proliferation and migration.